[Optimization of treatment of depression with administration of ethylmethylhydroxypyridine succinate (Mexicor)].

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)

Administration of Mexicor together with SSRIs leads to improved efficacy and tolerability of antidepressant therapy, and in the future, Mexicor may be recommended as an adjuvant in SSRI therapy for depression.

Keyphrases

depressive symptoms
sleep quality
major depressive disorder
open label
early stage
current status
randomized controlled trial
mesenchymal stem cells
combination therapy